Evidence map›Paper›PMID 28468971›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Paracrine IL-2 Is Required for Optimal Type 2 Effector Cytokine Production.

Matthew R Olson, Benjamin J Ulrich, Sarah A Hummel, Ibrahim Khan, Brice Meuris, Yesesri Cherukuri, Alexander L Dent, Sarath Chandra Janga, Mark H Kaplan

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.4field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. The role of IL-2 in type 2 immunity.Frontiers in immunology · 2025
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Matthew R OlsonDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; olsonmr@iupui.edu mkaplan2@iupui.edu.ORCID 0000-0003-2351-6002
Benjamin J UlrichDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0002-2729-1798
Sarah A HummelDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202.
Ibrahim KhanDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202.
Brice MeurisDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202.ORCID 0000-0001-6982-9819
Yesesri CherukuriSchool of Informatics and Computing, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202; and.ORCID 0000-0001-8309-1697
Alexander L DentDepartment of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202.
Sarath Chandra JangaSchool of Informatics and Computing, Indiana University-Purdue University Indianapolis, Indianapolis, IN 46202; and.ORCID 0000-0001-7351-6268
Mark H KaplanDepartment of Pediatrics, Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; olsonmr@iupui.edu mkaplan2@iupui.edu.ORCID 0000-0002-2923-8245
Indiana University – Purdue University Indianapolis · US

Funding

Project-005U54DK106846 · NIDDK · INDIANA UNIVERSITY INDIANAPOLIS · PI Reuben Kapur, Karen Elizabeth Pollok · 2015 to 2026
$9.7M
The role of PU.1 in T helper cell heterogeneityR01AI057459 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI KAPLAN, MARK H · 2005 to 2025
$8.2M
Immunology and Infectious Diseases Training ProgramT32AI060519 · NIAID · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI MARK H KAPLAN · 2004 to 2026
$6.0M
Indiana Medical Scientist/Engineer Training ProgramT32GM077229 · NIGMS · INDIANA UNIVERSITY INDIANAPOLIS · PI GASTON, BENJAMIN, HERBERT, BRITTNEY-SHEA · 2008 to 2022
$6.0M
The Indiana Cutaneous Biological Research Training ProgramT32AR062495 · NIAMS · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDROPHY, ELLIOT J. · 2013 to 2017
$649k
Granzyme A-secreting T cells in allergic inflammationR21AI117380 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2015 to 2016
$429k
STAT3 in T helper cell developmentR03AI101628 · NIAID · INDIANA UNIVERSITY INDIANAPOLIS · PI KAPLAN, MARK H · 2012 to 2013
$156k
NIAID NIH HHS R01 AI057459NIAID NIH HHS R03 AI101628NIAID NIH HHS R21 AI117380NIAID NIH HHS T32 AI060519NIAMS NIH HHS T32 AR062495NIDDK NIH HHS U54 DK106846NIGMS NIH HHS T32 GM077229
6 · The paper itself

Abstract

IL-2 is a pleiotropic cytokine that promotes the differentiation of Th cell subsets, including Th1, Th2, and Th9 cells, but it impairs the development of Th17 and T follicular helper cells. Although IL-2 is produced by all polarized Th subsets to some level, how it impacts cytokine production when effector T cells are restimulated is unknown. We show in this article that Golgi transport inhibitors (GTIs) blocked IL-9 production. Mechanistically, GTIs blocked secretion of IL-2 that normally feeds back in a paracrine manner to promote STAT5 activation and IL-9 production. IL-2 feedback had no effect on Th1- or Th17-signature cytokine production, but it promoted Th2- and Th9-associated cytokine expression. These data suggest that the use of GTIs results in an underestimation of the presence of type 2 cytokine-secreting cells and highlight IL-2 as a critical component in optimal cytokine production by Th2 and Th9 cells in vitro and in vivo.

Indexed as

Paracrine CommunicationAnimalsBrefeldin ACell DifferentiationCytokinesInterleukin-2Interleukin-9Lymphocyte ActivationMiceMice, Inbred C57BLMonensinProtein Synthesis InhibitorsProton IonophoresSTAT5 Transcription FactorTh17 CellsTh1 CellsBrefeldin ACytokinesInterleukin-2Interleukin-9MonensinProtein Synthesis InhibitorsProton IonophoresSTAT5 Transcription Factor

Identifiers

PMID28468971
PMCPMC5470780
OpenAlexW2610279359

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.